Fulltext

E42. Patterns of Tocilizumab Use and Safety in Patients with Rheumatoid Arthritis: Interim Results from Act-Up: A Multinational Observational Study

Haraoui, Boulos ; Casado, Gustavo ; Theander, Elke ; Czirják, Laszlo ; Taylor, Andrew ; Button, Peter ; Hinsch Gylvin, Lykke ; Caporali, Roberto

In: Rheumatology, 2015, vol. 54, p. i188-i188

Add to personal list
    Title
    • E42. Patterns of Tocilizumab Use and Safety in Patients with Rheumatoid Arthritis: Interim Results from Act-Up: A Multinational Observational Study
    Author
    • Haraoui, Boulos. Rheumatology Department, Institut de Rhumatologie, Montreal, QC, Canada, Médico Reumatólogo, Hospital Militar Central, Buenos Aires, Argentina, Department of Rheumatology, Skåne University Hospital Malmö, Lund University, Sweden, University of Pécs, Medical Centre, Pécs, Hungary, Rheumatology Department, Royal Perth Hospital, Perth, Medical Department, Roche Products Pty Limited, Dee Why, Australia, Medical Department, F Hoffmann-La Roche, Basel, Switzerland and University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy
    • Casado, Gustavo. Rheumatology Department, Institut de Rhumatologie, Montreal, QC, Canada, Médico Reumatólogo, Hospital Militar Central, Buenos Aires, Argentina, Department of Rheumatology, Skåne University Hospital Malmö, Lund University, Sweden, University of Pécs, Medical Centre, Pécs, Hungary, Rheumatology Department, Royal Perth Hospital, Perth, Medical Department, Roche Products Pty Limited, Dee Why, Australia, Medical Department, F Hoffmann-La Roche, Basel, Switzerland and University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy
    • Theander, Elke. Rheumatology Department, Institut de Rhumatologie, Montreal, QC, Canada, Médico Reumatólogo, Hospital Militar Central, Buenos Aires, Argentina, Department of Rheumatology, Skåne University Hospital Malmö, Lund University, Sweden, University of Pécs, Medical Centre, Pécs, Hungary, Rheumatology Department, Royal Perth Hospital, Perth, Medical Department, Roche Products Pty Limited, Dee Why, Australia, Medical Department, F Hoffmann-La Roche, Basel, Switzerland and University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy
    • Czirják, Laszlo. Rheumatology Department, Institut de Rhumatologie, Montreal, QC, Canada, Médico Reumatólogo, Hospital Militar Central, Buenos Aires, Argentina, Department of Rheumatology, Skåne University Hospital Malmö, Lund University, Sweden, University of Pécs, Medical Centre, Pécs, Hungary, Rheumatology Department, Royal Perth Hospital, Perth, Medical Department, Roche Products Pty Limited, Dee Why, Australia, Medical Department, F Hoffmann-La Roche, Basel, Switzerland and University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy
    • Taylor, Andrew. Rheumatology Department, Institut de Rhumatologie, Montreal, QC, Canada, Médico Reumatólogo, Hospital Militar Central, Buenos Aires, Argentina, Department of Rheumatology, Skåne University Hospital Malmö, Lund University, Sweden, University of Pécs, Medical Centre, Pécs, Hungary, Rheumatology Department, Royal Perth Hospital, Perth, Medical Department, Roche Products Pty Limited, Dee Why, Australia, Medical Department, F Hoffmann-La Roche, Basel, Switzerland and University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy
    • Button, Peter. Rheumatology Department, Institut de Rhumatologie, Montreal, QC, Canada, Médico Reumatólogo, Hospital Militar Central, Buenos Aires, Argentina, Department of Rheumatology, Skåne University Hospital Malmö, Lund University, Sweden, University of Pécs, Medical Centre, Pécs, Hungary, Rheumatology Department, Royal Perth Hospital, Perth, Medical Department, Roche Products Pty Limited, Dee Why, Australia, Medical Department, F Hoffmann-La Roche, Basel, Switzerland and University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy
    • Hinsch Gylvin, Lykke. Rheumatology Department, Institut de Rhumatologie, Montreal, QC, Canada, Médico Reumatólogo, Hospital Militar Central, Buenos Aires, Argentina, Department of Rheumatology, Skåne University Hospital Malmö, Lund University, Sweden, University of Pécs, Medical Centre, Pécs, Hungary, Rheumatology Department, Royal Perth Hospital, Perth, Medical Department, Roche Products Pty Limited, Dee Why, Australia, Medical Department, F Hoffmann-La Roche, Basel, Switzerland and University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy
    • Caporali, Roberto. Rheumatology Department, Institut de Rhumatologie, Montreal, QC, Canada, Médico Reumatólogo, Hospital Militar Central, Buenos Aires, Argentina, Department of Rheumatology, Skåne University Hospital Malmö, Lund University, Sweden, University of Pécs, Medical Centre, Pécs, Hungary, Rheumatology Department, Royal Perth Hospital, Perth, Medical Department, Roche Products Pty Limited, Dee Why, Australia, Medical Department, F Hoffmann-La Roche, Basel, Switzerland and University of Pavia, IRCCS S. Matteo Foundation, Pavia, Italy
    Document Type
    • Postprint
    OAI-PMH Identifier
    • oai:doc.rero.ch:295932